Membranous nephropathy

Common Name(s)

Membranous nephropathy

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Membranous nephropathy" for support, advocacy or research.

The NephCure Foundation

The NephCure Foundation is the only organization committed exclusively to support research seeking the cause of the potentially debilitating kidney disease Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic Syndrome, improve treatment and find a cure.

Last Updated: 30 Jan 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Membranous nephropathy" for support, advocacy or research.

The NephCure Foundation

The NephCure Foundation is the only organization committed exclusively to support research seeking the cause of the potentially debilitating kidney disease Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic Syndrome, improve treatment and find a cure.

http://www.nephcure.org

Last Updated: 30 Jan 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Membranous nephropathy" returned 227 free, full-text research articles on human participants. First 3 results:

Membranous nephropathy associated with sarcoidosis: a primary or secondary glomerulopathy?
 

Author(s): Tal Zilberman, Tanya Zahavi, Alexandra Osadchy, Naomi Nacasch, Ze'ev Korzets

Journal: Isr. Med. Assoc. J.. 2014 Jun;16(6):390-2.

 

Last Updated: 25 Jul 2014

Go To URL
Phosphotriesterase-related protein sensed albuminuria and conferred renal tubular cell activation in membranous nephropathy.
 

Author(s): Chao-Wen Cheng, Li-Chien Chang, Tzu-Ling Tseng, Chia-Chao Wu, Yuh-Feng Lin, Jin-Shuen Chen

Journal:

 

Membranous nephropathy (MN) is a common cause of nephrotic syndrome that may progress to end-stage renal disease (ESRD). The formation of MN involves the in situ formation of subepithelial immune deposits and leads to albuminuria; however, the underlying mechanism of how MN leads ...

Last Updated: 3 Jun 2014

Go To URL
Membranous nephropathy with acquired factor V inhibitor: a case report.
 

Author(s): Shinji Kitamura, Mahito Misawa, Sayaka Namba, Kenji Tsuji, Rikako Torigoe, Midori Shima, Hirofumi Makino

Journal:

 

Membranous nephropathy is one of the most common causes of nephrotic syndrome in adults. In contrast, acquired factor V inhibitor is a rare bleeding disorder.

Last Updated: 10 Jan 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Membranous nephropathy" returned 31 free, full-text review articles on human participants. First 3 results:

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.
 

Author(s): Yizhi Chen, Arrigo Schieppati, Guangyan Cai, Xiangmei Chen, Javier Zamora, Giovanni A Giuliano, Norbert Braun, Annalisa Perna

Journal: Clin J Am Soc Nephrol. 2013 May;8(5):787-96.

 

The efficacy and safety of immunosuppression for idiopathic membranous nephropathy (IMN) with nephrotic syndrome are still controversial. A systematic review and meta-analysis of randomized controlled trials (RCTs) was performed.

Last Updated: 8 May 2013

Go To URL
Treatment of idiopathic membranous nephropathy.
 

Author(s): Meryl Waldman, Howard A Austin

Journal: J. Am. Soc. Nephrol.. 2012 Oct;23(10):1617-30.

 

Exciting progress recently has been made in our understanding of idiopathic membranous nephropathy, as well as treatment of this disease. Here, we review important advances regarding the pathogenesis of membranous nephropathy. We will also review the current approach to treatment ...

Last Updated: 1 Oct 2012

Go To URL
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
 

Author(s): J M Hofstra, J F Wetzels

Journal: Neth J Med. 2012 Apr;70(3):109-13.

 

The identification of circulating autoantibodies against the M-type phospholipase A₂ receptor (anti-PLA₂R) in patients with idiopathic membranous nephropathy (iMN) has been a major discovery. Anti-PLA₂R can be measured by a commercially available test. It is suggested that measurement ...

Last Updated: 20 Apr 2012

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

MEmbranous Nephropathy Trial Of Rituximab
 

Status: Recruiting

Condition Summary: Idiopathic Membranous Nephropathy

 

Last Updated: 12 May 2014

Go to URL
Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
 

Status: Recruiting

Condition Summary: MEMBRANOUS NEPHROPATHY

 

Last Updated: 15 Sep 2014

Go to URL
Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
 

Status: Recruiting

Condition Summary: Idiopathic Membranous Nephropathy

 

Last Updated: 26 Feb 2014

Go to URL